Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Change in Acquisitions & Divestments (2022 - 2023)

Historic Change in Acquisitions & Divestments for Neuroone Medical Technologies (NMTC) over the last 2 years, with Q2 2023 value amounting to $1.0 million.

  • Neuroone Medical Technologies' Change in Acquisitions & Divestments changed N/A to $1.0 million in Q2 2023 from the same period last year, while for Sep 2023 it was $4.5 million, marking a year-over-year change of. This contributed to the annual value of $4.5 million for FY2023, which is 80000.0% up from last year.
  • Per Neuroone Medical Technologies' latest filing, its Change in Acquisitions & Divestments stood at $1.0 million for Q2 2023.
  • Neuroone Medical Technologies' Change in Acquisitions & Divestments' 5-year high stood at $2.0 million during Q1 2023, with a 5-year trough of $1.0 million in Q2 2023.